1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Accelerating Research Translation (ART) in Musculoskeletal and Skin Tissue Engineering and Regenerative Medicine (TE/RM) is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The NIAMS solicits Accelerating Research Translation (ART) applications in musculoskeletal and skin tissue engineering and regenerative medicine (TE/RM).
These awards offer revision support to active NIAMS R01, P01, and P50 (parent) grants for conducting large animal pre-clinical studies with the potential to immediately lead to human trials in musculoskeletal and skin TE/RM.
These studies should provide data for Phase I/II human clinical trials, demonstrate efficacy of a TE/RM therapy, or develop pre-clinical large animal models that can lead TE/RM research into Phase I/II clinical trials.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Recipients of active NIAMS R01, P01, and P50 (parent) grants. Confirm the full requirements in the official notice before applying.
The current listing shows $1 million total cost for 1-3 awards (FY 2011 funds). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Accelerating Research Translation (ART) in Musculoskeletal and Skin Tissue Engineering and Regenerative Medicine (TE/RM) is funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program